Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
Top Cited Papers
- 2 December 2010
- journal article
- research article
- Published by Elsevier
- Vol. 18 (6) , 553-567
- https://doi.org/10.1016/j.ccr.2010.11.015
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1Science, 2009
- Genome-Wide Determination of DNA Methylation by Hpa II Tiny Fragment Enrichment by Ligation-Mediated PCR (HELP) for the Study of Acute LeukemiasPublished by Springer Nature ,2009
- IDH1andIDH2Mutations in GliomasNew England Journal of Medicine, 2009
- An Integrated Genomic Analysis of Human Glioblastoma MultiformeScience, 2008
- A novel interaction between the proto‐oncogene Evi1 and histone methyltransferases, SUV39H1 and G9aFEBS Letters, 2008
- Comparative isoschizomer profiling of cytosine methylation: The HELP assayGenome Research, 2006
- JHDM2A, a JmjC-Containing H3K9 Demethylase, Facilitates Transcription Activation by Androgen ReceptorPublished by Elsevier ,2006
- Histone demethylation by a family of JmjC domain-containing proteinsNature, 2005
- PU.1 inhibits the erythroid program by binding to GATA-1 on DNA and creating a repressive chromatin structureThe EMBO Journal, 2005
- Probing tumor phenotypes using stable and regulated synthetic microRNA precursorsNature Genetics, 2005